Dr. Julien Berro's lab explores how physical forces impact cellular processes such as endocytosis, which is how cells take in nutrients and communicate. By developing innovative force sensors and protein engineering techniques, the lab aims to understand the mechanics behind these processes at a molecular level. This research could lead to new therapeutic strategies for diseases like cancer and metabolic disorders by leveraging mechanical signals to influence cell behavior.

The lab led by Dr. Jean-Leon Thomas at Yale University focuses on understanding how specialized blood vessels in the brain called meningeal lymphatic vessels influence the immune system during early development. The research emphasizes the relationship between these vessels and neuroimmune communication, particularly in relation to pediatric brain tumors like medulloblastoma. By utilizing advanced imaging techniques and genetic mouse models, the lab aims to uncover how these vessels can enhance T cell education and potentially improve treatments for childhood cancers.

Dr. Richard E. Carson's lab focuses on developing innovative radioligands for positron emission tomography (PET) to advance our understanding of mental health disorders. They explore the role of various molecular targets, such as receptors and transporters in the brain, that are implicated in conditions like depression and schizophrenia. By validating these radioligands, the lab aims to improve the diagnosis and treatment of mental health issues and contribute to the broader field of molecular neuroscience.

Scott J Miller's lab at Yale University focuses on developing new catalysts and chemical reactions to modify complex bioactive molecules, which are essential in drug discovery. The research aims to create efficient methods for synthesizing and diversifying drug candidates by targeting specific functional groups in these molecules. Overall, their work is poised to significantly advance the field of medicinal chemistry, particularly in creating novel therapeutics.

Dr. Evan D. Morris's lab at Yale University focuses on understanding how specific brain receptors affect behaviors associated with Alcohol Use Disorder (AUD). Through advanced imaging techniques and machine learning, the lab studies the imbalance between Mu and Kappa opioid receptors in the brain and how this impacts cravings and recovery outcomes for individuals trying to quit drinking. By identifying these relationships, the research aims to inform better treatment strategies for AUD.

Dr. R. Todd Constable's lab at Yale University is focused on advancing MRI technology and understanding the brain's functions and dysfunctions, particularly in relation to neuropsychiatric symptoms from infections like COVID-19. The lab works on making MRI more accessible through innovative low-cost systems, while also researching the brain circuits involved in cognitive and behavioral changes after illness. By merging neuroscience with advanced imaging techniques, they aim to develop better diagnostic and treatment strategies for patients with complex neurological disorders.

David R. Martinez's lab at Yale University is focused on developing innovative mucosal vaccines aimed at providing robust and long-lasting protection against respiratory viruses, particularly coronaviruses. The lab studies how specific adjuvants can enhance the immune response in the respiratory tract, looking to elicit protective IgA antibodies that can prevent the spread of infections. Through various experimental models, the lab aims to improve vaccination strategies to combat current and future viral threats.

Dr. Mandar Muzumdar's lab at Yale University focuses on understanding the complex interactions between diet, genetics, and pancreatic cancer development. Their research explores how dietary factors like fatty acids and medications such as incretin mimetics influence cancer risk and progression, particularly in pancreatic ductal adenocarcinoma (PDAC). They employ advanced techniques to determine molecular mechanisms and develop strategies for prevention and treatment.

Dr. Michael Koelle's lab at Yale University focuses on understanding how brain circuits work by studying the egg-laying behavior in the tiny roundworm C. elegans. The lab aims to pinpoint how various signaling molecules like neurotransmitters and neuropeptides contribute to the activity of these circuits, which can provide insights into human brain diseases. By using advanced techniques such as imaging and genetics, the lab investigates the interactions of different neurons and how they govern behavior.

Dr. Jesse Cedarbaum's research lab focuses on understanding and treating neurodegenerative diseases, particularly those related to synucleinopathies, like Parkinson's disease. The lab conducts clinical trials exploring the effectiveness of anti-TNF therapies to slow the progression of symptoms in patients with REM Sleep Behavior Disorder. By integrating advanced imaging techniques and immunological assessments, the team aims to uncover new insights into the inflammatory processes that may drive these disorders.

Dr. Jaime Grutzendler's lab focuses on understanding how two types of brain cells, microglia and astrocytes, interact in the context of Alzheimer's disease. The lab is investigating the protective roles these cells may play in wrapping around amyloid plaques, which are harmful clumps found in the brains of Alzheimer's patients. By using advanced imaging techniques, the researchers aim to uncover cellular interactions that could lead to new therapeutic strategies to protect neurons in Alzheimer's disease.

Dr. Rajit Manohar's lab at Yale University focuses on developing advanced devices for neuromodulation to better control epilepsy seizures. The lab works on creating low-power, programmable processors that can analyze brain signals and modulate neural activity in real-time. This research aims to enhance the treatment options available for patients who are resistant to conventional therapies.

The Ferguson lab at Yale University focuses on understanding how lysosomes function in neurons, particularly in the context of Alzheimer's disease. They investigate the proteins JIP3 and JIP4, which play crucial roles in regulating lysosome movement and signaling within nerve cells. By uncovering the mechanisms that affect lysosome behavior, the lab aims to contribute to the development of therapeutic strategies for neurodegenerative diseases.

Dr. Zhengxin Cai's lab focuses on improving the understanding and management of spinal cord injuries (SCI) through advanced imaging techniques. The lab uses a special PET imaging technology to visualize changes in the brain and spinal cord, which may help in diagnosing and tracking the recovery of patients with SCI. Their goal is to provide new insights into neuroplasticity and therapeutic effects, ultimately enhancing patient care and therapy outcomes.

Dr. Dianqing Wu's research lab at Yale University focuses on understanding the roles of neutrophils and their interaction with polyunsaturated fatty acids (PUFAs) in inflammation and heart health. The lab investigates novel mechanisms of lipid transport and signaling in immune cells, particularly looking at how these processes contribute to diseases like myocardial infarction and cancer. The insights gained aim to uncover potential therapeutic targets for treating inflammatory diseases and enhancing cancer immunotherapy.

Dr. Andres Hidalgo's lab focuses on understanding the diverse roles of neutrophils in the immune system, particularly how different types of neutrophils can influence inflammation, immune response, and tissue repair. Their research explores how neutrophils, which are often known for their role in fighting infections, can also be involved in processes like promoting healing and modulating the adaptive immune system. By investigating these unique functions, the lab aims to uncover new ways to harness neutrophil activity for therapeutic benefit in diseases such as cancer and chronic inflammation.

Dr. Clemens R. Scherzer's lab at Yale University focuses on understanding how genetic factors contribute to the progression of Parkinson's disease, particularly in relation to cognitive decline and dementia. The research aims to identify specific genetic markers that can predict the risk of developing dementia in Parkinson's patients, which could change how we approach treatment and management of the disease. By analyzing data from a large number of patients over time, the lab seeks to improve clinical outcomes for individuals affected by Parkinson's disease.

Dr. Chi Liu's lab at Yale University is focused on enhancing the accuracy and reliability of Positron Emission Tomography (PET) imaging through innovative deep learning techniques. By addressing the issue of high image noise in PET scans, the lab aims to develop software that transforms standard clinical images into high-quality outputs, ultimately improving clinical decision-making and patient outcomes. The lab collaborates with top academic centers and industry leaders to ensure that their advancements can be effectively integrated into clinical practice.

Dr. Dana C. Peters' lab focuses on improving cardiac MRI techniques to better diagnose heart failure, particularly heart failure with preserved ejection fraction (HFpEF), which is often challenging to identify with traditional methods. The lab is developing innovative MRI methods to measure diastolic function and the pressures in the heart that contribute to symptoms like unexplained breathlessness. Their research integrates advanced imaging techniques and deep learning to enhance the accuracy and reliability of cardiac evaluation, especially before and after exercise.

Dr. Jennifer A. Kim's research lab focuses on tackling post-traumatic epilepsy, a condition impacting many individuals recovering from traumatic brain injuries. By leveraging advanced data analysis techniques, including machine learning and neuroimaging, the lab aims to develop automated tools for predicting who is at risk for developing epilepsy after injury. This work could significantly improve patient outcomes by enabling early interventions based on individual risk factors.